Medications for obesity as preventatives: a public and patient safety issue

Thumbnail
Name:
Publisher version
Author
Flint, Stuart W
Brown, Adrian
Vázquez-Velázquez, Verónica
Hazlehurst, Jonathan M
Affiliation
University of Leeds; University College London; University College London Hospital NHS Trust; National Institute of Health Research; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán; University of Birmingham; University Hospitals Birmingham NHS Foundation Trust
Publication date
2024-11-26
Subject
Diseases & disorders of systemic, metabolic or environmental origin
Biochemistry
Public health. Health statistics. Occupational health. Health education
Endocrinology

Metadata
Show full item record
Abstract
No abstract available
Citation
Flint SW, Brown A, Vázquez-Velázquez V, Hazlehurst JM. Medications for obesity as preventatives: a public and patient safety issue. Lancet Diabetes Endocrinol. 2024 Dec;12(12):878-879. doi: 10.1016/S2213-8587(24)00319-X.
Type
Correspondence
Handle
http://hdl.handle.net/20.500.14200/6838
Additional Links
https://www.thelancet.com/journals/landia/home
DOI
10.1016/S2213-8587(24)00319-X
PMID
39608962
Journal
The Lancet Diabetes & Endocrinology
Publisher
The Lancet, Diabetes & Endocrinology
Collections